Recurrent Colorectal Polyps Require Advanced, Structured Endoscopic Management : Frontline Gastroenterology | May 2026

Introduction

Colorectal Polyps are identified in up to half of screening colonoscopies and represent key precursor lesions for Colorectal Cancer. Advances in endoscopic resection techniques have dramatically reduced the need for surgery; however, recurrence or residual neoplasia after initial polypectomy remains an important clinical challenge. Recurrence rates may approach 20%, particularly after piecemeal resection of large lesions.

Problem Statement

Optimal management strategies for recurrent or residual colorectal polyps remain incompletely standardized. Limited evidence exists regarding selection among repeat endoscopic therapy, advanced resection techniques and surgery, particularly in technically difficult or fibrotic lesions.

Summary

This review comprehensively evaluates current evidence regarding management of recurrent or residual colorectal polyps after initial polypectomy, with particular emphasis on advanced endoscopic approaches and strategies to minimize repeated interventions.

The review highlights that recurrence is strongly influenced by the initial resection technique. Piecemeal endoscopic mucosal resection (EMR) carries substantially higher recurrence risk compared with en bloc resection because microscopic residual neoplastic tissue may remain at resection margins. Larger lesion size, difficult location, multiplicity and lesion morphology additionally contribute to recurrence risk.

Several patient-related factors were also associated with recurrent neoplasia, including male sex, older age, obesity and smoking history. These observations reinforce the multifactorial biology underlying colorectal neoplasia persistence and recurrence.

A key theme throughout the review is the importance of expert initial resection. Incomplete primary therapy frequently converts otherwise manageable lesions into technically complex recurrent polyps characterized by fibrosis, scar formation and distorted tissue planes. These recurrent lesions are often substantially more difficult to eradicate than treatment-naïve lesions.

The review discusses a spectrum of advanced therapeutic options for recurrent lesions. Repeat EMR may remain feasible for smaller residual adenomas, whereas more advanced approaches such as Endoscopic Submucosal Dissection can facilitate en bloc excision of scarred or recurrent lesions. Avulsion techniques combined with thermal margin ablation have also emerged as valuable tools for fibrotic residual disease not amenable to standard snare capture.

The role of full-thickness endoscopic resection is additionally emphasized for selected nonlifting or heavily scarred lesions. These techniques may help avoid surgery in carefully selected patients while still achieving definitive resection.

Importantly, the review underscores that surgery remains necessary in selected circumstances, particularly when invasive malignancy is suspected, complete endoscopic excision is not feasible or repeated endoscopic attempts have failed. However, the authors strongly advocate referral to advanced endoscopy centers before surgical referral whenever possible, given the morbidity associated with colorectal resection.

A major practical message is that recurrent polyp management should ideally occur in highly experienced, well-resourced tertiary centers. Advanced imaging, expert lesion characterization and availability of multiple resection platforms are critical for maximizing endoscopic cure rates and minimizing repeated procedures.

The burden of recurrent procedures is also appropriately highlighted. Beyond technical complexity, repeated interventions increase patient anxiety, healthcare utilization, procedural risk and surveillance burden. Consequently, achieving high-quality definitive initial resection is likely the most effective recurrence-prevention strategy.

The review also reflects the broader evolution of therapeutic colonoscopy toward organ-preserving minimally invasive management. Increasingly sophisticated endoscopic techniques are now allowing successful treatment of lesions previously referred directly for surgery.

Overall, this review emphasizes that recurrent colorectal polyps represent a technically demanding but increasingly manageable clinical problem. Optimal outcomes depend on expert lesion assessment, advanced endoscopic resection capability and early referral to specialized centers, with the overarching goal of achieving definitive organ-preserving therapy while minimizing repeated interventions and unnecessary surgery.